Siwei Li
Impact in
-
- Cancer-related molecular mechanisms research
- Sensory Systems top 10%
Papers in
-
- RNA modifications and cancer 7
- Genomics and Phylogenetic Studies 3
- RNA and protein synthesis mechanisms 3
- Protein Degradation and Inhibitors 2
- Ubiquitin and proteasome pathways 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Co-authors
- Patrick A. Limbach (3 shared papers)Yi Sang (5 shared papers)Guofu Huang (3 shared papers)Jun Yang (3 shared papers)Xinmei Chen (1 shared paper)Zhixiang Wang (1 shared paper)Qian Wang (1 shared paper)Yi Wang (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)European Journal of Medicinal Chemistry (1 paper)Journal of the American Society for Mass Spectrometry (1 paper)Drug Metabolism and Pharmacokinetics (1 paper)International Journal of Biological Macromolecules (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Siwei Li
24 papers receiving 555 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 129
- Sensory Systems 38
- Molecular Biology 403
- Pharmaceutical Science 21
- Oncology 90
Countries citing papers authored by Siwei Li
This map shows the geographic impact of Siwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siwei Li more than expected).
Fields of papers citing papers by Siwei Li
This network shows the impact of papers produced by Siwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siwei Li. The network helps show where Siwei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Siwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 68 | |
| 2 | 2009 | 63 | |
| 3 | 2018 | 57 | |
| 4 | 2016 | 42 | |
| 5 | 2021 | 39 | |
| 6 | 2013 | 38 | |
| 7 | 2017 | 35 | |
| 8 | 2021 | 33 | |
| 9 | 2018 | 33 | |
| 10 | 2012 | 26 | |
| 11 | 2013 | 21 | |
| 12 | 2019 | 18 | |
| 13 | 2020 | 13 | |
| 14 | 2014 | 11 | |
| 15 | NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma. | 2018 | 11 |
| 16 | 2020 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2016 | 8 | |
| 19 | 2022 | 7 | |
| 20 | 2023 | 6 |
About Siwei Li
Siwei Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Epidemiology and Hematology, having authored 25 papers that have together received 556 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (4 papers), MicroRNA in disease regulation (3 papers), Genomics and Phylogenetic Studies (3 papers), RNA and protein synthesis mechanisms (3 papers), Protein Degradation and Inhibitors (2 papers), Ubiquitin and proteasome pathways (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (129 citations), Sensory Systems (38 citations), Molecular Biology (403 citations), Pharmaceutical Science (21 citations) and Oncology (90 citations). Siwei Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Patrick A. Limbach, Yi Sang, Guofu Huang, Jun Yang, Xinmei Chen, Zhixiang Wang, Qian Wang, Yi Wang, Duxin Sun and Lijuan Liu. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of the American Society for Mass Spectrometry, Drug Metabolism and Pharmacokinetics and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.